Growth Metrics

Artivion (AORT) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn 106.81%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 106.81%
Dec 31, 2025 92.92%
Sep 30, 2025 94.34%
Jun 30, 2025 144.68%
Mar 31, 2025 -208.63%
Dec 31, 2024 -6.45%
Sep 30, 2024 58.39%
Jun 30, 2024 -11.20%
Mar 31, 2024 10.74%
Dec 31, 2023 5,094.47%
Sep 30, 2023 81.89%
Jun 30, 2023 183.10%
Mar 31, 2023 -929.10%
Dec 31, 2022 -130.31%
Sep 30, 2022 236.68%
Jun 30, 2022 -414.09%
Mar 31, 2022 80.32%
Dec 31, 2021 -86.86%
Sep 30, 2021 -137.88%
Jun 30, 2021 177.97%
Mar 31, 2021 -215.33%
Dec 31, 2020 414.15%
Sep 30, 2020 -40.29%
Jun 30, 2020 -555.09%
Mar 31, 2020 126.96%
Dec 31, 2019 -89.92%
Sep 30, 2019 54.57%
Jun 30, 2019 -2.74%
Mar 31, 2019 111.94%
Dec 31, 2018 76.02%
Sep 30, 2018 196.72%
Jun 30, 2018 141.53%
Mar 31, 2018 -351.41%
Dec 31, 2017 18.47%
Sep 30, 2017 -68.27%
Jun 30, 2017 -141.71%
Mar 31, 2017 174.40%
Dec 31, 2016 256.54%
Sep 30, 2016 82.83%
Jun 30, 2016 13.66%
Mar 31, 2016 8.63%
Dec 31, 2015 -70.43%
Sep 30, 2015 93.01%
Jun 30, 2015 35.89%
Mar 31, 2015 163.69%
Dec 31, 2014 -12.44%
Sep 30, 2014 -65.57%
Jun 30, 2014 -44.91%
Mar 31, 2014 -74.34%
Dec 31, 2013 -31.53%
Sep 30, 2013 19.61%
Jun 30, 2013 66.63%
Mar 31, 2013 -164.76%
Dec 31, 2012 162.22%
Sep 30, 2012 4.56%
Jun 30, 2012 -22.43%
Mar 31, 2012 -53.31%
Dec 31, 2011 -56.61%
Sep 30, 2011 53.67%